near-significantp < 0.054
For QuickSIN, AMPH-enhanced performance approached significance for the 2.5 mg dose ( p < 0.06; d = 0.79); non-parametric comparisons also detected a near-significant effect at the 5 mg dose ( p < 0.054).
For QuickSIN, AMPH-enhanced performance approached significance for the 2.5 mg dose ( p < 0.06; d = 0.79); non-parametric comparisons also detected a near-significant effect at the 5 mg dose ( p < 0.054).
For WIN, compared to placebo, AMPH enhanced 4 dB performance at 2.5 and 5 mg doses ( p 's < 0.012 and d = 1.29 for each), and this effect approached significance for 10 mg AMPH ( p < 0.06; d = 0.98); these results were confirmed using non-parametric analyses (Wilcoxon signed-rank test: p < 0.016, 0.014 and 0.085 for 2.5, 5 and 10 mg AMPH v. placebo, respectively).